Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

Clinical trials

  • Neuroblastoma Maintenance Therapy Trial (NMTT)

    Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 ±…

    Investigator
    Joanne Lagmay
    Ages
    1 Year - 30 Years
    Sexes
    All
  • Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

    This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles…

    Investigator
    Joanne Lagmay
    Ages
    12 Months - 21 Years
    Sexes
    All